Anti‑B IgG Titre Test in Dubai | 130 AED | DHA Licensed

Executive Summary & Core Metrics

Executive Summary – Quantification of IgG antibodies against B antigen for antenatal and transfusion risk assessment, processed with 99.9% diagnostic sensitivity.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (8 AM–11 PM) for serum and EDTA whole blood samples.
Clinical Guidance: Complimentary Telephonic Post‑Test Result Interpretation by a DHA‑licensed physician.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Anti‑B IgG antibody titre test quantifies the concentration of IgG‑class antibodies against the B blood group antigen. It is primarily used in antenatal screening to predict haemolytic disease of the newborn and in transfusion medicine to ensure compatible blood products. The test employs Solid‑phase Erythrocyte Magnetized Technology (EMT Gel Card) for superior reproducibility compared to conventional tube agglutination.

Feature	Our Test (EMT Gel Card)	Standard Tube Agglutination
Method Precision	Solid‑phase Erythrocyte Magnetized Technology – high reproducibility	Visual tube agglutination – subjective endpoint
Sensitivity	99.9% at low titres (1:2 – 1:2048)	~95% ; prone to prozone effect
TAT / Reporting	Next‑day report (sample by 9 AM)	Often 48–72 hours
Sample Requirement	2 mL serum (SST) + 3 mL EDTA whole blood	3–5 mL serum only

Physician Insight & Safety Protocols

“As your attending physician, I emphasise that an isolated anti‑B IgG titre must always be correlated with the patient’s clinical history, ultrasound findings, and direct antiglobulin test (DAT) results. This test is one component of a comprehensive immunological assessment. Do not alter or discontinue any prescribed medication without consulting your doctor.”

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

🛡️ Safety & Exclusion Criteria

Exclusion: Active haemolytic episode; blood transfusion within the last 3 months (may cause false‑positive results).
Exclusion: Severe anaemia requiring immediate transfusion – do not delay emergency care for test collection.
Red Flags – Seek urgent medical attention: Sudden pallor, jaundice, dark urine, or a rapid drop in haemoglobin.
Sample integrity: DO NOT FREEZE samples; ship refrigerated at 2–8°C. Frozen specimens yield inaccurate titres.

Patient FAQ & Clinical Guidance

1. What is the purpose of the Anti‑B IgG titre test?

A: It measures the level of IgG antibodies against blood group B to predict the risk of haemolytic disease of the newborn and to guide transfusion compatibility decisions.

2. How is the sample collected for this test?

A: A 2 mL serum sample and a 3 mL EDTA whole blood tube are drawn via venipuncture, then transported refrigerated – never frozen – to maintain antibody integrity.

3. When will I receive my Anti‑B IgG titre results?

A: Results are reported the next day after the sample reaches our lab by 9 AM, enabling prompt clinical decisions for obstetric or haematological management.

UAE Regulatory & Data Privacy Adherence

This diagnostic service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted during transmission and storage, accessed only by authorised clinical personnel. Clinical safety and patient consent align with Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	Anti‑B IgG Titre
Price (AED)	130
Turnaround Time	Next day (if sample received by 9 AM)
Sample Type / Matrix	2 mL serum (SST) + 3 mL EDTA whole blood
Methodology Used	Solid‑phase Erythrocyte Magnetized Technology (EMT Gel Card)
ICD-10-CM Code	Z13.89
LOINC Code	51438-5
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE